EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
60.00
-4.00 (-6.25%)
At close: Dec 12, 2025
4.35% (1Y)
| Market Cap | 107.15M |
| Revenue (ttm) | 9.71M |
| Net Income (ttm) | 1.30M |
| Shares Out | 1.79M |
| EPS (ttm) | 0.73 |
| PE Ratio | 82.54 |
| Forward PE | n/a |
| Dividend | 1.83 (3.05%) |
| Ex-Dividend Date | n/a |
| Volume | 38 |
| Average Volume | 91 |
| Open | 60.00 |
| Previous Close | 64.00 |
| Day's Range | 60.00 - 60.00 |
| 52-Week Range | 55.00 - 65.50 |
| Beta | -0.04 |
| RSI | 42.96 |
| Earnings Date | Feb 10, 2026 |